Orthofix Medical (OFIX) Net Income towards Common Stockholders (2010 - 2026)

Orthofix Medical's Net Income towards Common Stockholders history runs 17 years deep, the most recent figure standing at -$20.9 million for Q1 2026.

• Quarterly Net Income towards Common Stockholders rose 60.62% year-over-year to -$20.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$41.2 million (up 70.79% YoY) and the FY2025 annual result came in at -$91.1 million, up 26.59% from the prior year.
• Net Income towards Common Stockholders was -$20.9 million for Q1 2026 at Orthofix Medical, down from -$1.1 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $3.6 million in Q2 2025 and bottomed at -$60.9 million in Q1 2023.
• A 5-year average of -$19.4 million and a median of -$20.9 million in 2026 frame the typical range for Net Income towards Common Stockholders.
• Peak annual rise in Net Income towards Common Stockholders reached 110.78% in 2025, while the deepest fall reached 24255.05% in 2025.
• Orthofix Medical's Net Income towards Common Stockholders stood at -$5.8 million in 2022, then sank by 279.43% to -$22.2 million in 2023, then declined by 22.95% to -$27.3 million in 2024, then jumped by 95.82% to -$1.1 million in 2025, then tumbled by 1734.04% to -$20.9 million in 2026.
• Business Quant data shows OFIX's Net Income towards Common Stockholders at -$20.9 million in Q1 2026, -$1.1 million in Q4 2025, and -$22.8 million in Q3 2025.